NCT03382314View on ClinicalTrials.gov

HDDO-1614 Bio Equivalence Study

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

October 16, 2017

Primary Completion Date

December 21, 2017

Study Completion Date

January 5, 2018

Conditions
Osteoporosis
Interventions
COMBINATION_PRODUCT

HDDO-1614

"* Combination drug (Bazedoxifene + Cholecalciferol)~* Incrementally modified drug~* Not market authorized product"

DRUG

Bazedoxifene / Cholecalciferol

Co- Administration of Bazedoxifene and Cholecalciferol

Trial Locations (1)

22332

Inha University Hospital, Junggu

Sponsors
All Listed Sponsors
lead

Hyundai Pharmaceutical Co., LTD.

INDUSTRY